Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
Scott R. Plotkin et al.
NEURO-ONCOLOGY (2023)
The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis
Nader Salari et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2023)
Tamoxifen Exerts Anticancer Effects on Pituitary Adenoma Progression via Inducing Cell Apoptosis and Inhibiting Cell Migration
Tingting Lv et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Individualized medical treatment options in Cushing disease
Aleksandra Gilis-Januszewska et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors
Azusa Yamato et al.
COMMUNICATIONS BIOLOGY (2022)
Mifepristone: A Safe Method of Medical Abortion and Self-Managed Medical Abortion in the Post-Roe Era
Elizabeth O. Schmidt et al.
AMERICAN JOURNAL OF THERAPEUTICS (2022)
Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues
Lorenzo Vagnoni et al.
NEUROSURGICAL REVIEW (2022)
Drug repurposing for breast cancer therapy: Old weapon for new battle
Sadhna Aggarwal et al.
SEMINARS IN CANCER BIOLOGY (2021)
Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways
Liemei Guo et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions
Christian Ogasawara et al.
BIOMEDICINES (2021)
Brain and other central nervous system tumor statistics, 2021
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Metformin suppresses self-renewal and stemness of cancer stem cell models derived from pluripotent stem cells
Maram H. Zahra et al.
CELL BIOCHEMISTRY AND FUNCTION (2021)
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
Ryota Tamura
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Epidemiologic Study of Primary Brain Tumors in Miyazaki Prefecture: A Regional 10-year Survey in Southern Japan
Fumitaka Matsumoto et al.
NEUROLOGIA MEDICO-CHIRURGICA (2021)
Drug repositioning in cancer: The current situation in Japan
Takaaki Masuda et al.
CANCER SCIENCE (2020)
Definition and diagnosis of aggressive pituitary tumors
Leandro Kasuki et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
Jacqueline Trouillas et al.
CANCERS (2020)
A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s
Federica Guaraldi et al.
CLINICAL ENDOCRINOLOGY (2020)
Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma
Akimichi Morita et al.
JOURNAL OF DERMATOLOGY (2020)
Drug repositioning: a brief overview
Jean-Pierre Jourdan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management
Taylor Anne Wilson et al.
FRONTIERS IN ONCOLOGY (2020)
Bexarotene combined with lapatinib for the treatment of Cushing's disease: evidence based on drug repositioning and experimental confirmation
Haoying Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion
Ryota Tamura et al.
ENDOCRINE PATHOLOGY (2019)
NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss
Jessica E. Sagers et al.
HEARING RESEARCH (2019)
COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
Felix Behling et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
Andrea Emanuele Guerini et al.
CANCERS (2019)
Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
Imogen M. Roth et al.
FRONTIERS IN ONCOLOGY (2019)
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas
Jeffrey R. Gehlhausen et al.
HUMAN MOLECULAR GENETICS (2019)
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma
Scott R. Plotkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Expression of Components of the Renin-Angiotensin System by the Putative Stem Cell Population Within WHO Grade I Meningioma
Ganeshwaran Shivapathasundram et al.
FRONTIERS IN SURGERY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas
Jamie J. Van Gompel et al.
NEUROSURGERY (2018)
Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
Benjamin M. Wahle et al.
ONCOTARGET (2018)
Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas
Ivo J. Kruyt et al.
JOURNAL OF NEUROSURGERY (2018)
Aspirin Does Not Prevent Growth of Vestibular Schwannomas: A Case-Control Study
Samuel MacKeith et al.
LARYNGOSCOPE (2018)
Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway
Jaroon Wandee et al.
LIFE SCIENCES (2018)
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
Jessica E. Sagers et al.
SCIENTIFIC REPORTS (2018)
Dual role of macrophage in tumor immunity
Ryota Tamura et al.
IMMUNOTHERAPY (2018)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Guido Rindi et al.
MODERN PATHOLOGY (2018)
Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma
Christine G. Skibinski et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells
Nipun Saini et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2018)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
The pharmacogenomics of valproic acid
Miao-Miao Zhu et al.
JOURNAL OF HUMAN GENETICS (2017)
(Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway
Masaaki Kouchi et al.
JOURNAL OF NEUROSURGERY (2017)
Vestibular Schwannoma Growth With Aspirin and Other Nonsteroidal Anti-inflammatory Drugs
Jacob B. Hunter et al.
OTOLOGY & NEUROTOLOGY (2017)
NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapy
Hiroshi Nakanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells
Jiayin An et al.
ONCOTARGET (2017)
The Stem Cell Connection of Pituitary Tumors
Hugo Vankelecom et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response
Ryota Tamura et al.
BRAIN TUMOR PATHOLOGY (2017)
YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis
William Guerrant et al.
CANCER RESEARCH (2016)
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
Roberto Wuerth et al.
DRUG DISCOVERY TODAY (2016)
Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7
Monireh Afzali et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies
Michael Karsy et al.
WORLD NEUROSURGERY (2016)
Computational and Practical Aspects of Drug Repositioning
Tudor I. Oprea et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
Pituitary tumors contain a side population with tumor stem cell-associated characteristics
Freya Mertens et al.
ENDOCRINE-RELATED CANCER (2015)
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
Jack Cuzick et al.
LANCET ONCOLOGY (2015)
Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression
Yachao Zhao et al.
MOLECULAR MEDICINE REPORTS (2015)
Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth
Sonam Dilwali et al.
MOLECULAR ONCOLOGY (2015)
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas
Sonam Dilwali et al.
TRANSLATIONAL RESEARCH (2015)
Valproic acid promotes radiosensitization in meningioma stemlike cells
Hsin-Ying Clair Chiou et al.
ONCOTARGET (2015)
Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
Andrew R. Larsen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2015)
The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis
Paula de Robles et al.
NEURO-ONCOLOGY (2015)
Management of aggressive pituitary adenomas and pituitary carcinomas
Anthony Heaney
JOURNAL OF NEURO-ONCOLOGY (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Aspirin Intake Correlates With Halted Growth of Sporadic Vestibular Schwannoma In Vivo
Cherian K. Kandathil et al.
OTOLOGY & NEUROTOLOGY (2014)
Molecular mechanism of action of metformin: old or new insights?
Graham Rena et al.
DIABETOLOGIA (2013)
Multifaceted roles of PGE2 in inflammation and cancer
Masako Nakanishi et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Drug repositioning: a machine-learning approach through data integration
Francesco Napolitano et al.
JOURNAL OF CHEMINFORMATICS (2013)
Drug Repurposing: Far Beyond New Targets for Old Drugs
T. I. Oprea et al.
AAPS JOURNAL (2012)
The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells
Tullio Florio et al.
DRUG DISCOVERY TODAY (2012)
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Steven M. Paul et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Isolation of tumour stem-like cells from benign tumours
Q. Xu et al.
BRITISH JOURNAL OF CANCER (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
EFFECT OF SIMVASTATIN ON GLIOMA CELL PROLIFERATION, MIGRATION, AND APOPTOSIS
Hongtao Wu et al.
NEUROSURGERY (2009)
Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase
MD Johnson et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Aspirin inhibits NF-κB and protects from angiotensin II-induced organ damage
DN Muller et al.
FASEB JOURNAL (2001)
Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice
RL Jensen et al.
SURGICAL NEUROLOGY (2001)
Share Paper
